{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:42:11Z","timestamp":1790840531947,"version":"4.1.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,7,11]],"date-time":"2017-07-11T00:00:00Z","timestamp":1499731200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1038\/mp.2017.142","type":"journal-article","created":{"date-parts":[[2017,7,11]],"date-time":"2017-07-11T09:32:01Z","timestamp":1499765521000},"page":"1530-1540","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Synaptic activity protects against AD and FTD-like pathology via autophagic-lysosomal degradation"],"prefix":"10.1038","volume":"23","author":[{"given":"Y","family":"Akwa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Gondard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Capetillo-Zarate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Alberdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Matute","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Marty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Vaccari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A M","family":"Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E E","family":"Baulieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Tampellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,11]]},"reference":[{"key":"BFmp2017142_CR1","first-page":"1","volume":"2","author":"TA Bayer","year":"2010","unstructured":"Bayer TA, Wirths O . Intracellular accumulation of amyloid-beta - a predictor for synaptic dysfunction and neuron loss in Alzheimer's disease. Front Aging Neurosci 2010; 2: 1\u201310.","journal-title":"Front Aging Neurosci"},{"key":"BFmp2017142_CR2","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00401-010-0679-9","volume":"119","author":"GK Gouras","year":"2010","unstructured":"Gouras GK, Tampellini D, Takahashi RH, Capetillo-Zarate E . Intraneuronal beta-amyloid accumulation and synapse pathology in Alzheimer's disease. Acta Neuropathol 2010; 119: 523\u2013541.","journal-title":"Acta Neuropathol"},{"key":"BFmp2017142_CR3","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1016\/j.ajpath.2012.06.033","volume":"181","author":"HC Tai","year":"2012","unstructured":"Tai HC, Serrano-Pozo A, Hashimoto T, Frosch MP, Spires-Jones TL, Hyman BT . The synaptic accumulation of hyperphosphorylated tau oligomers in Alzheimer disease is associated with dysfunction of the ubiquitin-proteasome system. Am J Pathol 2012; 181: 1426\u20131435.","journal-title":"Am J Pathol"},{"key":"BFmp2017142_CR4","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1002\/jnr.22392","volume":"88","author":"R Clare","year":"2010","unstructured":"Clare R, King VG, Wirenfeldt M, Vinters HV . Synapse loss in dementias. J Neurosci Res 2010; 88: 2083\u20132090.","journal-title":"J Neurosci Res"},{"key":"BFmp2017142_CR5","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1126\/science.1074069","volume":"298","author":"DJ Selkoe","year":"2002","unstructured":"Selkoe DJ . Alzheimer's disease is a synaptic failure. Science 2002; 298: 789\u2013791.","journal-title":"Science"},{"key":"BFmp2017142_CR6","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/ana.410270502","volume":"27","author":"ST DeKosky","year":"1990","unstructured":"DeKosky ST, Scheff SW . Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann Neurol 1990; 27: 457\u2013464.","journal-title":"Ann Neurol"},{"key":"BFmp2017142_CR7","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/ana.410300410","volume":"30","author":"RD Terry","year":"1991","unstructured":"Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R et al. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 1991; 30: 572\u2013580.","journal-title":"Ann Neurol"},{"issue":"Spec No 2","key":"BFmp2017142_CR8","doi-asserted-by":"publisher","first-page":"S160","DOI":"10.1259\/bjr\/97295129","volume":"80","author":"K Herholz","year":"2007","unstructured":"Herholz K, Carter SF, Jones M . Positron emission tomography imaging in dementia. Br J Radiol 2007; 80 (Spec No 2): S160\u2013S167.","journal-title":"Br J Radiol"},{"key":"BFmp2017142_CR9","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1212\/WNL.0b013e3181e3966e","volume":"74","author":"JL O'Brien","year":"2010","unstructured":"O'Brien JL, O'Keefe KM, LaViolette PS, DeLuca AN, Blacker D, Dickerson BC et al. Longitudinal fMRI in elderly reveals loss of hippocampal activation with clinical decline. Neurology 2010; 74: 1969\u20131976.","journal-title":"Neurology"},{"key":"BFmp2017142_CR10","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1515\/rns.2011.035","volume":"22","author":"C Marchetti","year":"2011","unstructured":"Marchetti C, Marie H . Hippocampal synaptic plasticity in Alzheimer's disease: what have we learned so far from transgenic models? Rev Neurosci 2011; 22: 373\u2013402.","journal-title":"Rev Neurosci"},{"key":"BFmp2017142_CR11","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1073\/pnas.2635903100","volume":"101","author":"EM Reiman","year":"2004","unstructured":"Reiman EM, Chen K, Alexander GE, Caselli RJ, Bandy D, Osborne D et al. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc Natl Acad Sci USA 2004; 101: 284\u2013289.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFmp2017142_CR12","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neuron.2009.07.003","volume":"63","author":"RA Sperling","year":"2009","unstructured":"Sperling RA, Laviolette PS, O'Keefe K, O'Brien J, Rentz DM, Pihlajamaki M et al. Amyloid deposition is associated with impaired default network function in older persons without dementia. Neuron 2009; 63: 178\u2013188.","journal-title":"Neuron"},{"key":"BFmp2017142_CR13","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/nature17172","volume":"531","author":"DS Roy","year":"2016","unstructured":"Roy DS, Arons A, Mitchell TI, Pignatelli M, Ryan TJ, Tonegawa S . Memory retrieval by activating engram cells in mouse models of early Alzheimer's disease. Nature 2016; 531: 508\u2013512.","journal-title":"Nature"},{"key":"BFmp2017142_CR14","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.exger.2010.08.028","volume":"46","author":"DF Swaab","year":"2010","unstructured":"Swaab DF, Bao AM . (Re-)activation of neurons in aging and dementia: lessons from the hypothalamus. Exp Gerontol 2010; 46: 178\u2013184.","journal-title":"Exp Gerontol"},{"key":"BFmp2017142_CR15","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3389\/fnins.2015.00423","volume":"9","author":"D Tampellini","year":"2015","unstructured":"Tampellini D . Synaptic activity and Alzheimer's disease: a critical update. Front Neurosci 2015; 9: 423.","journal-title":"Front Neurosci"},{"key":"BFmp2017142_CR16","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.mod.2012.09.008","volume":"130","author":"C Bas-Orth","year":"2013","unstructured":"Bas-Orth C, Bading H . The divergence-convergence model of acquired neuroprotection. Mech Dev 2013; 130: 396\u2013401.","journal-title":"Mech Dev"},{"key":"BFmp2017142_CR17","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.bbadis.2014.04.019","volume":"1842","author":"AE Ramirez","year":"2014","unstructured":"Ramirez AE, Pacheco CR, Aguayo LG, Opazo CM . Rapamycin protects against Abeta-induced synaptotoxicity by increasing presynaptic activity in hippocampal neurons. Biochim Biophys Acta 2014; 1842: 1495\u20131501.","journal-title":"Biochim Biophys Acta"},{"key":"BFmp2017142_CR18","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.cell.2013.12.042","volume":"156","author":"V Rangaraju","year":"2014","unstructured":"Rangaraju V, Calloway N, Ryan TA . Activity-driven local ATP synthesis is required for synaptic function. Cell 2014; 156: 825\u2013835.","journal-title":"Cell"},{"key":"BFmp2017142_CR19","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1001\/archneurol.2012.590","volume":"69","author":"GS Smith","year":"2012","unstructured":"Smith GS, Laxton AW, Tang-Wai DF, McAndrews MP, Diaconescu AO, Workman CI et al. Increased cerebral metabolism after 1 year of deep brain stimulation in Alzheimer disease. Arch Neurol 2012; 69: 1141\u20131148.","journal-title":"Arch Neurol"},{"key":"BFmp2017142_CR20","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.brs.2014.11.020","volume":"8","author":"T Sankar","year":"2015","unstructured":"Sankar T, Chakravarty MM, Bescos A, Lara M, Obuchi T, Laxton AW et al. Deep brain stimulation influences brain structure in Alzheimer's disease. Brain Stimul 2015; 8: 645\u2013654.","journal-title":"Brain Stimul"},{"key":"BFmp2017142_CR21","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.neuron.2005.10.028","volume":"48","author":"JR Cirrito","year":"2005","unstructured":"Cirrito JR, Yamada KA, Finn MB, Sloviter RS, Bales KR, May PC et al. Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. Neuron 2005; 48: 913\u2013922.","journal-title":"Neuron"},{"key":"BFmp2017142_CR22","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S0896-6273(03)00124-7","volume":"37","author":"F Kamenetz","year":"2003","unstructured":"Kamenetz F, Tomita T, Hsieh H, Seabrook G, Borchelt D, Iwatsubo T et al. APP processing and synaptic function. Neuron 2003; 37: 925\u2013937.","journal-title":"Neuron"},{"key":"BFmp2017142_CR23","first-page":"1","volume":"2","author":"D Tampellini","year":"2010","unstructured":"Tampellini D, Gouras GK . Synapses, synaptic activity and intraneuronal Abeta in Alzheimer's disease. Front Aging Neurosci 2010; 2: 1\u20135.","journal-title":"Front Aging Neurosci"},{"key":"BFmp2017142_CR24","doi-asserted-by":"publisher","first-page":"9704","DOI":"10.1523\/JNEUROSCI.2292-09.2009","volume":"29","author":"D Tampellini","year":"2009","unstructured":"Tampellini D, Rahman N, Gallo EF, Huang Z, Dumont M, Capetillo-Zarate E et al. Synaptic activity reduces intraneuronal Abeta, promotes APP transport to synapses, and protects against Abeta-related synaptic alterations. J Neurosci 2009; 29: 9704\u20139713.","journal-title":"J Neurosci"},{"key":"BFmp2017142_CR25","doi-asserted-by":"publisher","first-page":"14299","DOI":"10.1523\/JNEUROSCI.3383-10.2010","volume":"30","author":"D Tampellini","year":"2010","unstructured":"Tampellini D, Capetillo-Zarate E, Dumont M, Huang Z, Yu F, Lin MT et al. Effects of synaptic modulation on {beta}-amyloid, synaptophysin, and memory performance in Alzheimer's disease transgenic mice. J Neurosci 2010; 30: 14299\u201314304.","journal-title":"J Neurosci"},{"key":"BFmp2017142_CR26","doi-asserted-by":"publisher","first-page":"15384","DOI":"10.1523\/JNEUROSCI.2986-11.2011","volume":"31","author":"D Tampellini","year":"2011","unstructured":"Tampellini D, Rahman N, Lin MT, Capetillo-Zarate E, Gouras GK . Impaired beta-amyloid secretion in Alzheimer's disease pathogenesis. J Neurosci 2011; 31: 15384\u201315390.","journal-title":"J Neurosci"},{"key":"BFmp2017142_CR27","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/embor.2013.15","volume":"14","author":"AM Pooler","year":"2013","unstructured":"Pooler AM, Phillips EC, Lau DH, Noble W, Hanger DP . Physiological release of endogenous tau is stimulated by neuronal activity. EMBO Rep 2013; 14: 389\u2013394.","journal-title":"EMBO Rep"},{"key":"BFmp2017142_CR28","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1084\/jem.20131685","volume":"211","author":"K Yamada","year":"2014","unstructured":"Yamada K, Holth JK, Liao F, Stewart FR, Mahan TE, Jiang H et al. Neuronal activity regulates extracellular tau in vivo. J Exp Med 2014; 211: 387\u2013393.","journal-title":"J Exp Med"},{"key":"BFmp2017142_CR29","doi-asserted-by":"publisher","first-page":"6084","DOI":"10.1523\/JNEUROSCI.4261-13.2014","volume":"34","author":"ML Frandemiche","year":"2014","unstructured":"Frandemiche ML, De Seranno S, Rush T, Borel E, Elie A, Arnal I et al. Activity-dependent tau protein translocation to excitatory synapse is disrupted by exposure to amyloid-beta oligomers. J Neurosci 2014; 34: 6084\u20136097.","journal-title":"J Neurosci"},{"key":"BFmp2017142_CR30","doi-asserted-by":"publisher","first-page":"13469","DOI":"10.1523\/JNEUROSCI.3100-11.2011","volume":"31","author":"SS Stone","year":"2011","unstructured":"Stone SS, Teixeira CM, Devito LM, Zaslavsky K, Josselyn SA, Lozano AM et al. Stimulation of entorhinal cortex promotes adult neurogenesis and facilitates spatial memory. J Neurosci 2011; 31: 13469\u201313484.","journal-title":"J Neurosci"},{"key":"BFmp2017142_CR31","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1073\/pnas.77.4.2333","volume":"77","author":"MT Wong-Riley","year":"1980","unstructured":"Wong-Riley MT, Welt C . Histochemical changes in cytochrome oxidase of cortical barrels after vibrissal removal in neonatal and adult mice. Proc Natl Acad Sci USA 1980; 77: 2333\u20132337.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFmp2017142_CR32","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","volume":"39","author":"S Oddo","year":"2003","unstructured":"Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R et al. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 2003; 39: 409\u2013421.","journal-title":"Neuron"},{"key":"BFmp2017142_CR33","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","volume":"53","author":"Y Yoshiyama","year":"2007","unstructured":"Yoshiyama Y, Higuchi M, Zhang B, Huang SM, Iwata N, Saido TC et al. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 2007; 53: 337\u2013351.","journal-title":"Neuron"},{"key":"BFmp2017142_CR34","doi-asserted-by":"publisher","first-page":"18895","DOI":"10.1074\/jbc.M700373200","volume":"282","author":"D Tampellini","year":"2007","unstructured":"Tampellini D, Magrane J, Takahashi RH, Li F, Lin MT, Almeida CG et al. Internalized antibodies to the Abeta domain of APP reduce neuronal Abeta and protect against synaptic alterations. J Biol Chem 2007; 282: 18895\u201318906.","journal-title":"J Biol Chem"},{"key":"BFmp2017142_CR35","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.nbd.2005.02.008","volume":"20","author":"CG Almeida","year":"2005","unstructured":"Almeida CG, Tampellini D, Takahashi RH, Greengard P, Lin MT, Snyder EM et al. Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses. Neurobiol Dis 2005; 20: 187\u2013198.","journal-title":"Neurobiol Dis"},{"key":"BFmp2017142_CR36","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.neuropharm.2014.01.037","volume":"81","author":"S Revilla","year":"2014","unstructured":"Revilla S, Sunol C, Garcia-Mesa Y, Gimenez-Llort L, Sanfeliu C, Cristofol R . Physical exercise improves synaptic dysfunction and recovers the loss of survival factors in 3xTg-AD mouse brain. Neuropharmacology 2014; 81: 55\u201363.","journal-title":"Neuropharmacology"},{"key":"BFmp2017142_CR37","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0896-6273(01)00194-5","volume":"29","author":"W Lu","year":"2001","unstructured":"Lu W, Man H, Ju W, Trimble WS, MacDonald JF, Wang YT . Activation of synaptic NMDA receptors induces membrane insertion of new AMPA receptors and LTP in cultured hippocampal neurons. Neuron 2001; 29: 243\u2013254.","journal-title":"Neuron"},{"key":"BFmp2017142_CR38","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1038\/nature04769","volume":"441","author":"B Bingol","year":"2006","unstructured":"Bingol B, Schuman EM . Activity-dependent dynamics and sequestration of proteasomes in dendritic spines. Nature 2006; 441: 1144\u20131148.","journal-title":"Nature"},{"key":"BFmp2017142_CR39","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3389\/fneur.2013.00122","volume":"4","author":"AS Chesser","year":"2013","unstructured":"Chesser AS, Pritchard SM, Johnson GV . Tau clearance mechanisms and their possible role in the pathogenesis of Alzheimer disease. Front Neurol 2013; 4: 122.","journal-title":"Front Neurol"},{"key":"BFmp2017142_CR40","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.pneurobio.2013.03.001","volume":"105","author":"MJ Lee","year":"2013","unstructured":"Lee MJ, Lee JH, Rubinsztein DC . Tau degradation: the ubiquitin-proteasome system versus the autophagy-lysosome system. Prog Neurobiol 2013; 105: 49\u201359.","journal-title":"Prog Neurobiol"},{"key":"BFmp2017142_CR41","doi-asserted-by":"publisher","first-page":"13107","DOI":"10.1074\/jbc.M110.100420","volume":"285","author":"A Caccamo","year":"2010","unstructured":"Caccamo A, Majumder S, Richardson A, Strong R, Oddo S . Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments. J Biol Chem 2010; 285: 13107\u201313120.","journal-title":"J Biol Chem"},{"issue":"Pt 7","key":"BFmp2017142_CR42","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1093\/brain\/aws143","volume":"135","author":"V Schaeffer","year":"2012","unstructured":"Schaeffer V, Lavenir I, Ozcelik S, Tolnay M, Winkler DT, Goedert M . Stimulation of autophagy reduces neurodegeneration in a mouse model of human tauopathy. Brain 2012; 135 (Pt 7): 2169\u20132177.","journal-title":"Brain"},{"key":"BFmp2017142_CR43","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1046\/j.1365-2990.2002.00394.x","volume":"28","author":"E Kuusisto","year":"2002","unstructured":"Kuusisto E, Salminen A, Alafuzoff I . Early accumulation of p62 in neurofibrillary tangles in Alzheimer's disease: possible role in tangle formation. Neuropathol Appl Neurobiol 2002; 28: 228\u2013237.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"BFmp2017142_CR44","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1471-4159.2008.05340.x","volume":"106","author":"J Ramesh Babu","year":"2008","unstructured":"Ramesh Babu J, Lamar Seibenhener M, Peng J, Strom AL, Kemppainen R, Cox N et al. Genetic inactivation of p62 leads to accumulation of hyperphosphorylated tau and neurodegeneration. J Neurochem 2008; 106: 107\u2013120.","journal-title":"J Neurochem"},{"key":"BFmp2017142_CR45","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.tcm.2012.05.015","volume":"21","author":"H Su","year":"2011","unstructured":"Su H, Wang X . p62 Stages an interplay between the ubiquitin-proteasome system and autophagy in the heart of defense against proteotoxic stress. Trends Cardiovasc Med 2011; 21: 224\u2013228.","journal-title":"Trends Cardiovasc Med"},{"key":"BFmp2017142_CR46","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0002-9440(10)64538-5","volume":"157","author":"AM Cataldo","year":"2000","unstructured":"Cataldo AM, Peterhoff CM, Troncoso JC, Gomez-Isla T, Hyman BT, Nixon RA . Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. Am J Pathol 2000; 157: 277\u2013286.","journal-title":"Am J Pathol"},{"key":"BFmp2017142_CR47","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1101\/cshperspect.a006361","volume":"2","author":"Y Ihara","year":"2012","unstructured":"Ihara Y, Morishima-Kawashima M, Nixon R . The ubiquitin-proteasome system and the autophagic-lysosomal system in Alzheimer disease. Cold Spring Harb Perspect Med 2012; 2: 2\u201327.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"BFmp2017142_CR48","doi-asserted-by":"publisher","first-page":"a016931","DOI":"10.1101\/cshperspect.a016931","volume":"6","author":"FR Maxfield","year":"2014","unstructured":"Maxfield FR . Role of endosomes and lysosomes in human disease. Cold Spring Harb Perspect Biol 2014; 6: a016931.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"BFmp2017142_CR49","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.nbd.2011.01.021","volume":"43","author":"RA Nixon","year":"2011","unstructured":"Nixon RA, Yang DS . Autophagy failure in Alzheimer's disease\u2014locating the primary defect. Neurobiol Dis 2011; 43: 38\u201345.","journal-title":"Neurobiol Dis"},{"key":"BFmp2017142_CR50","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1111\/j.1460-9568.2008.06084.x","volume":"27","author":"T Hamano","year":"2008","unstructured":"Hamano T, Gendron TF, Causevic E, Yen SH, Lin WL, Isidoro C et al. Autophagic-lysosomal perturbation enhances tau aggregation in transfectants with induced wild-type tau expression. Eur J Neurosci 2008; 27: 1119\u20131130.","journal-title":"Eur J Neurosci"},{"key":"BFmp2017142_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15548627.2015.1100356","volume":"12","author":"DJ Klionsky","year":"2016","unstructured":"Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A et al. Guidelines for the use and interpretation of assays for monitoring autophagy(3rd edition). Autophagy 2016; 12: 1\u2013222.","journal-title":"Autophagy"},{"key":"BFmp2017142_CR52","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.neures.2005.11.009","volume":"54","author":"S Maeda","year":"2006","unstructured":"Maeda S, Sahara N, Saito Y, Murayama S, Ikai A, Takashima A . Increased levels of granular tau oligomers: an early sign of brain aging and Alzheimer's disease. Neurosci Res 2006; 54: 197\u2013201.","journal-title":"Neurosci Res"},{"key":"BFmp2017142_CR53","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3233\/JAD-2008-14406","volume":"14","author":"KR Brunden","year":"2008","unstructured":"Brunden KR, Trojanowski JQ, Lee VM . Evidence that non-fibrillar tau causes pathology linked to neurodegeneration and behavioral impairments. J Alzheimers Dis 2008; 14: 393\u2013399.","journal-title":"J Alzheimers Dis"},{"key":"BFmp2017142_CR54","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1126\/science.316.5830.1416","volume":"316","author":"J Marx","year":"2007","unstructured":"Marx J . Alzheimer's disease. A new take on tau. Science 2007; 316: 1416\u20131417.","journal-title":"Science"},{"key":"BFmp2017142_CR55","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.4161\/auto.21488","volume":"8","author":"V Schaeffer","year":"2012","unstructured":"Schaeffer V, Goedert M . Stimulation of autophagy is neuroprotective in a mouse model of human tauopathy. Autophagy 2012; 8: 1686\u20131687.","journal-title":"Autophagy"},{"key":"BFmp2017142_CR56","first-page":"1","volume":"30","author":"A Caccamo","year":"2016","unstructured":"Caccamo A, Ferreira E, Branca C, Oddo S . p62 improves AD-like pathology by increasing autophagy. Mol Psychiatry 2016; 30: 1\u20139.","journal-title":"Mol Psychiatry"},{"key":"BFmp2017142_CR57","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.neuron.2017.01.022","volume":"93","author":"FM Menzies","year":"2017","unstructured":"Menzies FM, Fleming A, Caricasole A, Bento CF, Andrews SP, Ashkenazi A et al. Autophagy and neurodegeneration: pathogenic mechanisms and therapeutic opportunities. Neuron 2017; 93: 1015\u20131034.","journal-title":"Neuron"},{"key":"BFmp2017142_CR58","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1006\/nbdi.2000.0364","volume":"8","author":"K Ditaranto","year":"2001","unstructured":"Ditaranto K, Tekirian TL, Yang AJ . Lysosomal membrane damage in soluble Abeta-mediated cell death in Alzheimer's disease. Neurobiol Dis 2001; 8: 19\u201331.","journal-title":"Neurobiol Dis"},{"key":"BFmp2017142_CR59","doi-asserted-by":"publisher","first-page":"112","DOI":"10.15252\/emmm.201606965","volume":"9","author":"I Sambri","year":"2017","unstructured":"Sambri I, D'Alessio R, Ezhova Y, Giuliano T, Sorrentino NC, Cacace V et al. Lysosomal dysfunction disrupts presynaptic maintenance and restoration of presynaptic function prevents neurodegeneration in lysosomal storage diseases. EMBO Mol Med 2017; 9: 112\u2013132.","journal-title":"EMBO Mol Med"},{"key":"BFmp2017142_CR60","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.15252\/emmm.201303671","volume":"6","author":"VA Polito","year":"2014","unstructured":"Polito VA, Li H, Martini-Stoica H, Wang B, Yang L, Xu Y et al. Selective clearance of aberrant tau proteins and rescue of neurotoxicity by transcription factor EB. EMBO Mol Med 2014; 6: 1142\u20131160.","journal-title":"EMBO Mol Med"},{"key":"BFmp2017142_CR61","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/ncb3114","volume":"17","author":"DL Medina","year":"2015","unstructured":"Medina DL, Di Paola S, Peluso I, Armani A, De Stefani D, Venditti R et al. Lysosomal calcium signalling regulates autophagy through calcineurin and TFEB. Nat Cell Biol 2015; 17: 288\u2013299.","journal-title":"Nat Cell Biol"},{"key":"BFmp2017142_CR62","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.1093\/hmg\/ddp367","volume":"18","author":"Y Wang","year":"2009","unstructured":"Wang Y, Martinez-Vicente M, Kruger U, Kaushik S, Wong E, Mandelkow EM et al. Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing. Hum Mol Genet 2009; 18: 4153\u20134170.","journal-title":"Hum Mol Genet"},{"key":"BFmp2017142_CR63","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.neuron.2015.11.008","volume":"88","author":"PS McPherson","year":"2015","unstructured":"McPherson PS . Eating locally: microautophagy and protein turnover at the synapse. Neuron 2015; 88: 619\u2013621.","journal-title":"Neuron"},{"key":"BFmp2017142_CR64","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.neuron.2015.10.012","volume":"88","author":"V Uytterhoeven","year":"2015","unstructured":"Uytterhoeven V, Lauwers E, Maes I, Miskiewicz K, Melo MN, Swerts J et al. Hsc70-4 deforms membranes to promote synaptic protein turnover by endosomal microautophagy. Neuron 2015; 88: 735\u2013748.","journal-title":"Neuron"},{"key":"BFmp2017142_CR65","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1083\/jcb.201106120","volume":"196","author":"S Maday","year":"2012","unstructured":"Maday S, Wallace KE, Holzbaur EL . Autophagosomes initiate distally and mature during transport toward the cell soma in primary neurons. J Cell Biol 2012; 196: 407\u2013417.","journal-title":"J Cell Biol"},{"key":"BFmp2017142_CR66","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.devcel.2011.07.016","volume":"21","author":"DL Medina","year":"2011","unstructured":"Medina DL, Fraldi A, Bouche V, Annunziata F, Mansueto G, Spampanato C et al. Transcriptional activation of lysosomal exocytosis promotes cellular clearance. Dev Cell 2011; 21: 421\u2013430.","journal-title":"Dev Cell"},{"key":"BFmp2017142_CR67","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1038\/nn.4328","volume":"19","author":"JW Wu","year":"2016","unstructured":"Wu JW, Hussaini SA, Bastille IM, Rodriguez GA, Mrejeru A, Rilett K et al. Neuronal activity enhances tau propagation and tau pathology in vivo. Nat Neurosci 2016; 19: 1085\u20131092.","journal-title":"Nat Neurosci"},{"key":"BFmp2017142_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2014.08.014","volume":"36","author":"A Stargardt","year":"2015","unstructured":"Stargardt A, Swaab DF, Bossers K . The storm before the quiet: neuronal hyperactivity and Abeta in the presymptomatic stages of Alzheimer's disease. Neurobiol Aging 2015; 36: 1\u201311.","journal-title":"Neurobiol Aging"},{"key":"BFmp2017142_CR69","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1038\/nn.3806","volume":"17","author":"JA Elman","year":"2014","unstructured":"Elman JA, Oh H, Madison CM, Baker SL, Vogel JW, Marks SM et al. Neural compensation in older people with brain amyloid-beta deposition. Nat Neurosci 2014; 17: 1316\u20131318.","journal-title":"Nat Neurosci"},{"issue":"3 Suppl 2","key":"BFmp2017142_CR70","doi-asserted-by":"publisher","first-page":"S69","DOI":"10.1097\/00002093-200607001-00010","volume":"20","author":"Y Stern","year":"2006","unstructured":"Stern Y . Cognitive reserve and Alzheimer disease. Alzheimer Dis Assoc Disord 2006; 20 (3 Suppl 2): S69\u2013S74.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"BFmp2017142_CR71","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1001\/jama.1994.03510370056032","volume":"271","author":"Y Stern","year":"1994","unstructured":"Stern Y, Gurland B, Tatemichi TK, Tang MX, Wilder D, Mayeux R . Influence of education and occupation on the incidence of Alzheimer's disease. JAMA 1994; 271: 1004\u20131010.","journal-title":"JAMA"},{"key":"BFmp2017142_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnint.2012.00002","volume":"6","author":"G Pizzolato","year":"2012","unstructured":"Pizzolato G, Mandat T . Deep brain stimulation for movement disorders. Front Integr Neurosci 2012; 6: 1\u20135.","journal-title":"Front Integr Neurosci"},{"key":"BFmp2017142_CR73","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3171\/2015.6.JNS15716","volume":"125","author":"FA Ponce","year":"2016","unstructured":"Ponce FA, Asaad WF, Foote KD, Anderson WS, Rees Cosgrove G, Baltuch GH et al. Bilateral deep brain stimulation of the fornix for Alzheimer's disease: surgical safety in the ADvance trial. J Neurosurg 2016; 125: 75\u201384.","journal-title":"J Neurosurg"},{"key":"BFmp2017142_CR74","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/ana.22089","volume":"68","author":"AW Laxton","year":"2010","unstructured":"Laxton AW, Tang-Wai DF, McAndrews MP, Zumsteg D, Wennberg R, Keren R et al. A phase I trial of deep brain stimulation of memory circuits in Alzheimer's disease. Ann Neurol 2010; 68: 521\u2013534.","journal-title":"Ann Neurol"},{"key":"BFmp2017142_CR75","doi-asserted-by":"publisher","first-page":"777","DOI":"10.3233\/JAD-160017","volume":"54","author":"AM Lozano","year":"2016","unstructured":"Lozano AM, Fosdick L, Chakravarty MM, Leoutsakos JM, Munro C, Oh E et al. A phase II study of fornix deep brain stimulation in mild Alzheimer's disease. J Alzheimers Dis 2016; 54: 777\u2013787.","journal-title":"J Alzheimers Dis"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/mp2017142.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/mp2017142","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/mp.2017.142","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/mp2017142.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T18:17:10Z","timestamp":1684433830000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/mp2017142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,11]]},"references-count":75,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["BFmp2017142"],"URL":"https:\/\/doi.org\/10.1038\/mp.2017.142","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,11]]},"assertion":[{"value":"13 December 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}